Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child–Pugh grade correlated with prognosis after transarterial chemoembolization

Koichiro Yamakado,Shiro Miyayama,Shozo Hirota,Kimiyoshi Mizunuma,Kenji Nakamura,Yoshitaka Inaba,Hiroaki Maeda,Kunihiro Matsuo,Norifumi Nishida,Takeshi Aramaki,Hiroshi Anai,Shinichi Koura,Shigeo Oikawa,Ken Watanabe,Taku Yasumoto,Kinya Furuichi,Masato Yamaguchi

Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child–Pugh grade correlated with prognosis after transarterial chemoembolization

2014

Koichiro Yamakado
Shiro Miyayama
Shozo Hirota
Kimiyoshi Mizunuma
Kenji Nakamura
Yoshitaka Inaba
Hiroaki Maeda
Kunihiro Matsuo
Norifumi Nishida
Takeshi Aramaki
Hiroshi Anai
Shinichi Koura
Shigeo Oikawa
Ken Watanabe
Taku Yasumoto
Kinya Furuichi
Masato Yamaguchi

Purpose To find a subgroup that benefits most from transarterial chemoembolization (TACE) in terms of tumor number and size and liver profile in patients with intermediate-stage hepatocellular carcinoma (HCC).

Keywords:

Radiology
BCLC Stage B Hepatocellular Carcinoma
Hepatocellular carcinoma
Arterial Embolization
Child-Pugh - Grade
Medicine
Radiation therapy
intermediate stage
in patient
Oncology
Carcinoma
Internal medicine
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations